U.S. Infrastructure Stock News

NasdaqGS:CMPR
NasdaqGS:CMPRCommercial Services

Is Cimpress (CMPR) Pricing Reflect Its Large DCF Upside And High P/E Multiple?

If you are trying to figure out whether Cimpress at around US$74 per share still offers value, you will want to see how the current price lines up against different valuation checks. The stock has seen a mix of moves recently, with a 1.8% decline over the past week and a 6.9% decline over the past month, while still showing returns of 13.1% year to date and 37.9% over the past year. Investors have been reacting to ongoing business updates and broader sentiment around Cimpress, which have...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

FDA Flu Ruling Tests Moderna Regulatory Assumptions And mRNA Pipeline Timing

FDA declined to review Moderna’s mRNA flu vaccine application, despite prior agreement on study design. The decision reportedly went against the recommendations of career FDA scientists. Regulatory setback raises questions for Moderna’s broader mRNA vaccine pipeline and timelines. For investors following Moderna, NasdaqGS:MRNA, this FDA decision cuts to the core of its investment story as a vaccine focused mRNA platform company. The company has been working to extend its mRNA technology...
NYSE:PCG
NYSE:PCGElectric Utilities

PG&E Storm Readiness Offers Fresh Insight Into Risk And Valuation

PG&E (NYSE:PCG) is preparing for a major winter storm by pre-positioning crews, equipment, and support teams across its service territory. The company has activated its Emergency Operations Center and developed response plans aimed at managing potential power outages and service disruptions. These steps are focused on customer safety, grid reliability, and managing weather-related and wildfire-related risks during the upcoming storm period. PG&E is a large regulated electric and gas utility...
NasdaqGS:DPZ
NasdaqGS:DPZHospitality

Domino's Philanthropy Surge And India Expansion Could Be A Game Changer For Domino's Pizza (DPZ)

In 2025, Domino's Pizza Inc. reported raising an all-time high of more than US$19.00 million for St. Jude Children's Research Hospital, taking its total contributions since the partnership began to over US$162.00 million and supporting its pledge made in May 2024 to reach US$300.00 million in fundraising by 2034. At the same time, India's Domino's operator Jubilant FoodWorks recorded a very large third-quarter profit increase and rapid store expansion, highlighting how franchise partners in...
NYSE:NET
NYSE:NETIT

Cloudflare Legal Leadership Shift Highlights Regulatory And Profitability Questions

Cloudflare (NYSE:NET) announced that Chief Legal Officer Doug Kramer will step down after nearly a decade in the role. Deputy Chief Legal Officer Alissa Starzak is set to succeed Kramer, providing an internal succession plan. The transition comes as Cloudflare continues to focus on growth and product expansion in internet security and performance. For investors watching NYSE:NET, this legal leadership change comes at a time when the stock trades around $195.85. Over the past 3 years, the...
NasdaqGS:SBUX
NasdaqGS:SBUXHospitality

Is Starbucks (SBUX) Share Price Justified After Recent Turnaround Focus?

If you are wondering whether Starbucks at around US$93.79 is priced for a comeback or still has work to do, you are not alone. This article will help you frame that question around value. The stock is up 0.9% over the last 30 days and 11.7% year to date, but over 1 year it has returned 14.4% and over 5 years 1.8%. This leaves many investors asking how today’s price stacks up against the company’s fundamentals. Recent attention on Starbucks has focused on how the brand is executing on its...
NasdaqGS:LBRD.K
NasdaqGS:LBRD.KMedia

Liberty Broadband Insider Sale Tests Confidence After Earnings Swing And Buybacks

Liberty Broadband director David Wargo has recently sold a significant number of company shares. The transaction involves Liberty Broadband stock trading around $55.6 under ticker NasdaqGS:LBRD.K. The scale of the sale is drawing attention from shareholders who track insider activity as a potential sentiment signal. For investors watching Liberty Broadband, the insider sale comes against a mixed return profile. The share price is around $55.6, with the stock up 3.4% over the past week and...
NYSE:RVTY
NYSE:RVTYLife Sciences

Revvity Expands Drug Discovery Tools As Investors Weigh Growth And Valuation

Revvity (NYSE:RVTY) introduced several new discovery platforms at SLAS2026, aimed at speeding up high-throughput drug discovery workflows. The launches include an advanced high-content screening system, a multimode plate reader, and a compact liquid handler for integrated lab setups. These products expand Revvity's portfolio in life sciences tools and are designed to support more efficient discovery programs. For investors watching NYSE:RVTY, this product launch comes as the shares trade at...
NYSE:LVS
NYSE:LVSHospitality

Is Las Vegas Sands’ Leadership Consolidation Under Patrick Dumont Reshaping the Investment Case for LVS?

Las Vegas Sands announced on February 13, 2026 that Patrick Dumont will become chairman and chief executive officer on March 1, 2026, with long-time leader Robert G. Goldstein moving to a senior advisor role through March 2028 and Dumont also chairing Hong Kong–listed Sands China. This leadership consolidation places an experienced internal executive, who has overseen large-scale Macao and Singapore investments including an US$8.00 billion ultra-luxury Singapore project, at the center of...
NYSE:CPT
NYSE:CPTResidential REITs

A Look At Camden Property Trust (CPT) Valuation After Earnings Beat Buyback And Dividend Increase

Camden Property Trust (CPT) reported fourth quarter and full year 2025 results that showed higher sales and net income, along with a new US$600 million share repurchase plan and a higher first quarter 2026 dividend. See our latest analysis for Camden Property Trust. Camden’s recent earnings beat, new US$600 million buyback plan, and higher dividend come after a 6.25% 90 day share price return. However, the 1 year total shareholder return of a 5.34% decline suggests longer term performance has...
NYSE:LADR
NYSE:LADRMortgage REITs

A Look At Ladder Capital (LADR) Valuation After Softer Q4 Earnings And Office Loan Losses

What triggered the latest move in Ladder Capital? Ladder Capital (LADR) has been in focus after fourth quarter earnings came in below market expectations. Management cited lower net interest income, loan paydowns and realized losses on certain office loans. See our latest analysis for Ladder Capital. At a share price of US$10.38, Ladder Capital has recorded a 1 month share price decline of 7.24% and a year to date share price decline of 6.49%. Its 5 year total shareholder return of 43.60%...
NYSE:ITW
NYSE:ITWMachinery

Is Illinois Tool Works (ITW) Still Fairly Priced After Strong Multi‑Year Share Price Gains

If you are wondering whether Illinois Tool Works is still reasonably priced after its strong run, this article will walk through what the current share price might imply about value. The stock recently closed at US$299.60, with returns of 2.1% over the last 7 days, 13.7% over 30 days, 20.1% year to date, 19.0% over 1 year, 33.7% over 3 years and 67.0% over 5 years, which can change how investors think about both upside and risk. Recent coverage of Illinois Tool Works has focused on its...
NYSE:TMO
NYSE:TMOLife Sciences

Assessing Thermo Fisher Scientific (TMO) Valuation After Recent Share Price Weakness

Thermo Fisher Scientific stock: recent moves and context Thermo Fisher Scientific (TMO) has been on many investors’ radars after a stretch of weaker share performance, including a 18.4% decline over the past month and 11% over the past 3 months. See our latest analysis for Thermo Fisher Scientific. At a share price of US$504.82, Thermo Fisher Scientific’s recent 1 day, 7 day and 30 day share price declines suggest momentum has cooled, even though the 5 year total shareholder return of 6.81%...
NYSE:BMY
NYSE:BMYPharmaceuticals

Assessing Bristol-Myers Squibb (BMY) Valuation After Earnings Beat And Newer Drug Growth

Bristol-Myers Squibb (BMY) is back in focus after reporting fourth quarter and full year 2025 results that beat consensus expectations, with newer drugs and cost savings playing a key role. See our latest analysis for Bristol-Myers Squibb. The latest earnings beat and updates on the newer drug portfolio come after a strong run in the shares, with a 30 day share price return of 9.92% and a 90 day share price return of 29.76%. The 1 year total shareholder return of 18.38% sits against a weaker...
NasdaqGS:WB
NasdaqGS:WBInteractive Media and Services

Weibo’s 2026 Gala Role Highlights User Engagement And Valuation Debate

Weibo has been named the official copyright video partner for the CCTV 2026 Spring Festival Gala. This marks the twelfth consecutive year of collaboration between Weibo and the Gala. The new agreement includes fresh digital celebration experiences and large scale interactive features for users. Weibo, listed as NasdaqGS:WB, is extending a long running role at the heart of one of China’s most watched cultural events. The stock last closed at $10.01, with a 3 year return of 38.9% decline and...
NYSE:AAT
NYSE:AATREITs

A Look At American Assets Trust (AAT) Valuation After Weaker Earnings And A New Quarterly Dividend

American Assets Trust (AAT) is in focus after reporting fourth quarter and full year 2025 results that showed lower sales, revenue, and net income, alongside declaring a first quarter 2026 cash dividend. See our latest analysis for American Assets Trust. The earnings update and dividend declaration come as American Assets Trust’s share price trades at US$18.56, with a 1-month share price return of 3.23% but a 1-year total shareholder return decline of 10.97%. This suggests that recent...